American Century Companies Inc Halozyme Therapeutics, Inc. Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 851,287 shares of HALO stock, worth $40.5 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

851,287

Previous 821,266 3.66%

Holding current value

$40.5 Million

Previous $43 Million 13.26%

% of portfolio

0.03%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$51.3 - $64.42 $1.54 Million - $1.93 Million	30,021 Added 3.66%	851,287 $48.7 Million
Q2 2024 Aug 07, 2024	BUY	$37.81 - $52.4 $2.74 Million - $3.8 Million	72,544 Added 9.69%	821,266 $43 Million
Q1 2024 May 14, 2024	BUY	$33.68 - $41.95 $1.26 Million - $1.57 Million	37,487 Added 5.27%	748,722 $30.5 Million
Q4 2023 Feb 13, 2024	BUY	$33.32 - $42.1 $23.7 Million - $29.9 Million	711,235 New	711,235 $26.3 Million
Q3 2023 Nov 13, 2023	BUY	$36.46 - $44.03 $531,513 - $641,869	14,578 Added 2.35%	633,658 $24.2 Million
Q2 2023 Aug 14, 2023	BUY	$30.28 - $38.74 $2.67 Million - $3.42 Million	88,274 Added 16.63%	619,080 $22.3 Million
Q1 2023 May 11, 2023	SELL	$32.86 - $55.7 $2.24 Million - $3.79 Million	-68,037 Reduced 11.36%	530,806 $20.3 Million
Q4 2022 Feb 13, 2023	SELL	$40.06 - $59.44 $1.24 Million - $1.84 Million	-30,913 Reduced 4.91%	598,843 $34.1 Million
Q3 2022 Nov 14, 2022	BUY	$38.53 - $51.78 $693,578 - $932,091	18,001 Added 2.94%	629,756 $24.9 Million
Q2 2022 Aug 12, 2022	BUY	$37.35 - $48.3 $1.92 Million - $2.49 Million	51,501 Added 9.19%	611,755 $26.9 Million
Q1 2022 May 11, 2022	BUY	$31.97 - $41.06 $1.61 Million - $2.07 Million	50,347 Added 9.87%	560,254 $22.3 Million
Q4 2021 Feb 07, 2022	BUY	$31.82 - $40.75 $1.89 Million - $2.42 Million	59,283 Added 13.16%	509,907 $20.5 Million
Q3 2021 Nov 10, 2021	BUY	$38.47 - $46.42 $1.12 Million - $1.35 Million	29,171 Added 6.92%	450,624 $18.3 Million
Q2 2021 Aug 05, 2021	BUY	$38.84 - $51.31 $49,792 - $65,779	1,282 Added 0.31%	421,453 $19.1 Million
Q1 2021 May 14, 2021	SELL	$39.51 - $51.45 $990,357 - $1.29 Million	-25,066 Reduced 5.63%	420,171 $17.5 Million
Q4 2020 Feb 12, 2021	BUY	$25.81 - $43.62 $313,591 - $529,983	12,150 Added 2.81%	445,237 $19 Million
Q3 2020 Nov 13, 2020	SELL	$25.74 - $29.63 $1.39 Million - $1.6 Million	-53,966 Reduced 11.08%	433,087 $11.4 Million
Q2 2020 Aug 13, 2020	BUY	$16.25 - $26.81 $886,535 - $1.46 Million	54,556 Added 12.61%	487,053 $13.1 Million
Q1 2020 May 14, 2020	SELL	$13.9 - $21.83 $1.53 Million - $2.4 Million	-109,966 Reduced 20.27%	432,497 $7.78 Million
Q4 2019 Feb 12, 2020	SELL	$14.93 - $19.53 $237,805 - $311,073	-15,928 Reduced 2.85%	542,463 $9.62 Million
Q3 2019 Nov 13, 2019	BUY	$15.2 - $17.69 $267,763 - $311,627	17,616 Added 3.26%	558,391 $8.66 Million
Q2 2019 Aug 14, 2019	BUY	$14.75 - $17.26 $1.78 Million - $2.08 Million	120,441 Added 28.65%	540,775 $9.29 Million
Q1 2019 May 14, 2019	BUY	$13.94 - $17.58 $46,531 - $58,682	3,338 Added 0.8%	420,334 $0
Q4 2018 Feb 13, 2019	BUY	$13.33 - $18.66 $2.9 Million - $4.06 Million	217,379 Added 108.9%	416,996 $6.1 Million
Q3 2018 Nov 02, 2018	SELL	$16.68 - $18.41 $997,931 - $1.1 Million	-59,828 Reduced 23.06%	199,617 $3.63 Million
Q2 2018 Aug 08, 2018	SELL	$16.87 - $20.3 $2.07 Million - $2.49 Million	-122,905 Reduced 32.14%	259,445 $4.38 Million
Q1 2018 May 03, 2018	SELL	$17.06 - $21.2 $2.91 Million - $3.62 Million	-170,641 Reduced 30.86%	382,350 $7.49 Million
Q4 2017 Feb 02, 2018	BUY	$16.75 - $20.8 $4.64 Million - $5.76 Million	277,052 Added 100.4%	552,991 $11.2 Million
Q3 2017 Nov 01, 2017	BUY	$11.76 - $17.4 $3.25 Million - $4.8 Million	275,939	275,939 $4.79 Million

Others Institutions Holding HALO

# of Institutions

543

Shares Held

125M

Call Options Held

294K

Put Options Held

180K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Halozyme Therapeutics, Inc. Transaction History